PIN7 COST MINIMIZATION ANALYSIS OF ORAL VALGANCICLOVIR VS. INTRAVENOUS AND ORAL GANCICLOVIR IN THE PREVENTION OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN SOLID ORGAN TRANSPLANT RECIPIENTS
Nov 1, 2004, 00:00
10.1016/S1098-3015(10)66024-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)66024-X/fulltext
Title :
PIN7 COST MINIMIZATION ANALYSIS OF ORAL VALGANCICLOVIR VS. INTRAVENOUS AND ORAL GANCICLOVIR IN THE PREVENTION OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN SOLID ORGAN TRANSPLANT RECIPIENTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66024-X&doi=10.1016/S1098-3015(10)66024-X
First page :
Section Title :
Open access? :
No
Section Order :
393